Skip to content
Hormone Replacement Therapy after Cervical Cancer with Jason Wright episode artwork

Dec 25, 2023 25 min

Hormone Replacement Therapy after Cervical Cancer with Jason Wright

from IJGC Podcast Hosted by BMJ Group

In this rebroadcast episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jason Wright to discuss hormone replacement therapy after cervical cancer. Dr. Wright is the Sol Goldman Associate Professor and Chief of the Division of Gynecologic Oncology at Columbia University. Highlights: -Among cervical cancer patients <50 years of age who underwent surgery including oophorectomy or primary radiation, only 39% received estrogen replacement therapy. -In patients who did receive estrogen replacement therapy the duration of use was short, with a median of only 60 days. -Black patients were significantly less likely to receive estrogen replacement therapy than White patients.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Hormone Replacement Therapy after Cervical Cancer with Jason Wright

0:00 25:18

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of IJGC Podcast?

This episode is 25 minutes long.

When was this IJGC Podcast episode published?

This episode was published on December 25, 2023.

Can I download this IJGC Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.